1171823-91-8

Basic information

• Product Name: ethyl 2-(5-bromo-2,4-dimethoxybenzoyl)-3-(dimethylamino)acrylate
• Synonyms: ethyl 2-(5-bromo-2,4-dimethoxybenzoyl)-3-(dimethylamino)acrylate
• CAS NO: 1171823-91-8
• Molecular Weight: 386.243
• Mol File: 1171823-91-8.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: ethyl 2-(5-bromo-2,4-dimethoxybenzoyl)-3-(dimethylamino)acrylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 2-(5-bromo-2,4-dimethoxybenzoyl)-3-(dimethylamino)acrylate(1171823-91-8)
• EPA Substance Registry System: ethyl 2-(5-bromo-2,4-dimethoxybenzoyl)-3-(dimethylamino)acrylate(1171823-91-8)

Safety Data

• Hazardous Substances Data: 1171823-91-8(Hazardous Substances Data)

Upstream product

• 91-52-1 2,4 dimethoxybenzoic acid 
• 32246-20-1 5-bromo-2,4-dimethoxybenzoic acid 
• 182056-48-0 1-(5-bromo-2,4-dimethoxyphenyl)ethan-1-one 
• 829-20-9 2',4'-dimethoxyacetophenone 
• 949014-39-5 ethyl 3-(5-bromo-2,4-dimethoxyphenyl)-3-oxopropanoate 
• 4637-24-5 N,N-dimethyl-formamide dimethyl acetal 
• 924-99-2 ethyl 3-(dimethylamino)acrylate 

Downstream Products

• 1171823-92-9 (S)-ethyl 3-(1-hydroxy-3-methylbutan-2-ylamino)-2-(5-bromo-2,4-dimethoxybenzoyl)acrylate 
• 697761-98-1 elvitegravir 

Relevant articles and documents

Preparation method of elviravir

The invention provides a preparation method of elviravir, and belongs to the technical field of medicine preparation. According to the method, 2, 4-dimethoxybenzoic acid is used as a raw material and is sequentially subjected to a bromination reaction, an

A NEW PRODUCTION METHOD AND NEW INTERMEDIATES OF SYNTHESIS OF ELVITEGRAVIR

The present solution relates to an improved production method of elvitegravir of formula I, which is being clinically evaluated for treatment of HIV infection. Elvitegravir of formula I is produced via the intermediate of formula II, the preparation of which is also an object of the present solution.

PROCESS FOR PRODUCTION OF 4-OXOQUINOLINE COMPOUND

The present invention provides a compound useful as a synthetic intermediate for an anti-HIV agent having an integrase inhibitory activity, a production method thereof, and a production method of an anti-HIV agent using the synthetic intermediate. Specifi